Theriva Biologics, Inc.
Theriva Biologics develops oncolytic adenoviruses for cancer treatment.
10-QNov 12Latest SEC filing
Nov 13Latest story
November 2026
August 2026
July 2026
Theriva Biologics develops oncolytic adenoviruses for cancer treatment.
November 2026
August 2026
July 2026